ZA956991B - Methods of inhibiting ulcerative mucositis. - Google Patents

Methods of inhibiting ulcerative mucositis.

Info

Publication number
ZA956991B
ZA956991B ZA9506991A ZA956991A ZA956991B ZA 956991 B ZA956991 B ZA 956991B ZA 9506991 A ZA9506991 A ZA 9506991A ZA 956991 A ZA956991 A ZA 956991A ZA 956991 B ZA956991 B ZA 956991B
Authority
ZA
South Africa
Prior art keywords
methods
ulcerative mucositis
inhibiting
inhibiting ulcerative
mucositis
Prior art date
Application number
ZA9506991A
Other languages
English (en)
Inventor
George Joseph Cullinan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA956991B publication Critical patent/ZA956991B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA9506991A 1994-08-22 1995-08-21 Methods of inhibiting ulcerative mucositis. ZA956991B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/293,790 US5496828A (en) 1994-08-22 1994-08-22 Methods of inhibiting ulcerative mucositis

Publications (1)

Publication Number Publication Date
ZA956991B true ZA956991B (en) 1997-02-20

Family

ID=23130590

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9506991A ZA956991B (en) 1994-08-22 1995-08-21 Methods of inhibiting ulcerative mucositis.

Country Status (9)

Country Link
US (2) US5496828A (fr)
EP (1) EP0781132A4 (fr)
JP (1) JPH10504575A (fr)
AU (1) AU3332495A (fr)
CA (1) CA2198016A1 (fr)
IL (1) IL115019A0 (fr)
MX (1) MX9701325A (fr)
WO (1) WO1996005831A1 (fr)
ZA (1) ZA956991B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
JPH11510479A (ja) * 1995-06-07 1999-09-14 ネオルックス コーポレイション タモキシフェン類似体による心臓血管疾病の予防及び治療
US5788982A (en) * 1995-06-16 1998-08-04 Nadoolman; Wolffe Method and composition for treating oral pain using capsaicin
US5747509A (en) * 1996-06-03 1998-05-05 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
AU6959898A (en) * 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
WO1999034838A2 (fr) * 1998-01-06 1999-07-15 The University Of Virginia Patent Foundation Evaluation du fonctionnement des muqueuses par scintigraphie nucleaire
US5945089A (en) * 1998-11-05 1999-08-31 I-Dent International Corporation Method of treating mucositis
US7566740B2 (en) * 1998-10-06 2009-07-28 Bml Pharmaceuticals, Inc. Method of treating mucositis
ES2246234T3 (es) 1999-05-04 2006-02-16 Strakan International Limited Glicosidos de androgenos y actividad androgenica de los mismos.
EP1113007A1 (fr) * 1999-12-24 2001-07-04 Pfizer Inc. Composés de tétrahydroisoquinoline comme agonistes/antagonistes d'oestrogène
WO2003024391A2 (fr) * 2001-08-16 2003-03-27 Mucosal Therapeutics, Inc. Traitement et prevention de la mucosite chez les patients cancereux
JP3887588B2 (ja) * 2002-08-30 2007-02-28 株式会社リガク Ｘ線回折による応力測定法
WO2004032843A2 (fr) * 2002-10-07 2004-04-22 Orapharma, Inc. Formulations de tetracycline muco-adhesives
US20090143453A1 (en) * 2003-04-29 2009-06-04 Connie Erickson-Miller Methods for treating degenerative diseases/injuries
ITMI20040989A1 (it) * 2004-05-18 2004-08-18 Gentium Spa Uso del sulglicotide per iul trattamento delle mucositi
AU2005285040A1 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
AU2006214515A1 (en) * 2005-02-16 2006-08-24 Wyeth Use of estrogen receptor-b selective agonists for radiation-or chemotherapy-induced mucosistis and radiation cystitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
MX9701325A (es) 1997-05-31
JPH10504575A (ja) 1998-05-06
CA2198016A1 (fr) 1996-02-29
WO1996005831A1 (fr) 1996-02-29
US5496828A (en) 1996-03-05
IL115019A0 (en) 1995-12-08
EP0781132A4 (fr) 1999-01-07
EP0781132A1 (fr) 1997-07-02
US6274601B1 (en) 2001-08-14
AU3332495A (en) 1996-03-14

Similar Documents

Publication Publication Date Title
ZA956991B (en) Methods of inhibiting ulcerative mucositis.
GB9409003D0 (en) Locator
PH31545A (en) Inhibition of helicobacter.
GB9508375D0 (en) Improved marine riser
HUP9900112A3 (en) Preservation solution
ZA964682B (en) Methods of inhibiting melanoma.
GB9521806D0 (en) Preservation methods
GB2303832B (en) Ship
GB9413017D0 (en) Boat
DE69523450D1 (en) Inhibitor
PL316825A1 (en) Flavouring agent
GB2300591B (en) Joinery processes
TW317913U (en) Chain retainer
HUP9602964A2 (en) Gasket
GB9509540D0 (en) Versatile lock
GB9722556D0 (en) Methods
ZA9610466B (en) Borers
GB2285415B (en) Boat
GB9414902D0 (en) Methods
GB9409923D0 (en) Chemicals
GB9516623D0 (en) Cryonator or cryotory
GB2295191B (en) Lock
GR940200211U (en) Chromo-change of inscriptions.
GB9506480D0 (en) Memorials
AU127305S (en) Boat